 LONDON , Sept. 6, 2022 PRNewswire -- Virax Biolabs Group Limited Virax or the Company Nasdaq: VRAX, an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, today announced that Viraxs Chairman of the Board of Directors and Chief Executive Officer, Mr. 